Regeneron Pharmaceuticals, Inc. faces challenges with Eylea sales but sees growth from Dupixent and obesity drugs. Click for ...

For the first time in more than 20 years, a developer will complete multiple projects this large in this L.A. suburb.

Microsoft CEO Satya Nadella could be right about OpenAI's 2-year lead in developing ChatGPT as buyers ditch Copilot.